ImmunityBio, Inc.(IBRX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

IBRX ImmunityBio, Inc.

休市中 12-20 15:59:59 EST

2.62

-0.05

-1.87%

盘后2.65

+0.03+1.14%

19:54 EST

最高2.71	最低2.61	成交量788.65万
今开2.66	昨收2.67	日振幅3.61%
总市值19.13亿	流通市值4.19亿	总股本7.30亿
成交额2,075万	换手率4.93%	流通股本1.60亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"IBRX","market":"US","secType":"STK","nameCN":"ImmunityBio, Inc.","latestPrice":2.62,"timestamp":1734728399999,"preClose":2.67,"halted":0,"volume":7886461,"hourTrading":{"tag":"盘后","latestPrice":2.6499,"preClose":2.62,"latestTime":"19:54 EST","volume":156963,"amount":411571.8206,"timestamp":1734742451430},"delay":0,"floatShares":159812816,"shares":730164630,"eps":-0.877402,"marketStatus":"休市中","marketStatusCode":7,"change":-0.05,"latestTime":"12-20 15:59:59 EST","open":2.66,"high":2.7065,"low":2.61,"amount":20753583.321414,"amplitude":0.036142,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.877402,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1734944400000},"adr":0,"listingDate":1438056000000,"adjPreClose":2.67,"preHourTrading":{"tag":"盘前","latestPrice":2.7,"preClose":2.67,"latestTime":"09:28 EST","volume":38719,"amount":102177.466331,"timestamp":1734704935351},"postHourTrading":{"tag":"盘后","latestPrice":2.6499,"preClose":2.62,"latestTime":"19:54 EST","volume":156963,"amount":411571.8206,"timestamp":1734742451430},"volumeRatio":1.0072265236629927,"impliedVol":1.0603,"impliedVolPercentile":0.4087},"requestUrl":"/m/hq/s/IBRX","defaultTab":"news","newsList":[{"id":"2492961846","title":"Immunitybio, Inc.盘中异动 股价大跌5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492961846","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492961846?lang=zh_cn&edition=full","pubTime":"2024-12-17 23:11","pubTimestamp":1734448262,"startTime":"0","endTime":"0","summary":"北京时间2024年12月17日23时11分，Immunitybio, Inc.股票出现异动，股价大幅下挫5.07%。Immunitybio, Inc.股票所在的生物技术行业中，整体涨幅为0.44%。Immunitybio, Inc.公司简介：ImmunityBio Inc 是一家临床阶段的综合性生物技术公司，致力于发现，开发和商业化下一代免疫和细胞疗法，以增强天然免疫系统，驱动和维持免疫反应。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217231103a1f61bb2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217231103a1f61bb2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IBRX"],"gpt_icon":0},{"id":"2491379513","title":"Immunitybio, Inc.盘中异动 早盘股价大跌5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2491379513","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491379513?lang=zh_cn&edition=full","pubTime":"2024-12-13 23:07","pubTimestamp":1734102465,"startTime":"0","endTime":"0","summary":"北京时间2024年12月13日23时07分，Immunitybio, Inc.股票出现波动，股价急速下跌5.26%。Immunitybio, Inc.股票所在的生物技术行业中，整体跌幅为0.29%。Immunitybio, Inc.公司简介：ImmunityBio Inc 是一家临床阶段的综合性生物技术公司，致力于发现，开发和商业化下一代免疫和细胞疗法，以增强天然免疫系统，驱动和维持免疫反应。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213230745ab759ea6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213230745ab759ea6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IBRX"],"gpt_icon":0},{"id":"2490829673","title":"Immunitybio, Inc.盘中异动 早盘急速拉升5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490829673","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490829673?lang=zh_cn&edition=full","pubTime":"2024-12-12 22:32","pubTimestamp":1734013949,"startTime":"0","endTime":"0","summary":"北京时间2024年12月12日22时32分，Immunitybio, Inc.股票出现异动，股价急速拉升5.04%。Immunitybio, Inc.股票所在的生物技术行业中，整体跌幅为0.37%。Immunitybio, Inc.公司简介：ImmunityBio Inc 是一家临床阶段的综合性生物技术公司，致力于发现，开发和商业化下一代免疫和细胞疗法，以增强天然免疫系统，驱动和维持免疫反应。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212223229984b9684&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212223229984b9684&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IBRX"],"gpt_icon":0},{"id":"2490374862","title":"BUZZ--美国股票走势-Candel Therapeutics、Broadcom、Reddit","url":"https://stock-news.laohu8.com/highlight/detail?id=2490374862","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490374862?lang=zh_cn&edition=full","pubTime":"2024-12-12 00:18","pubTimestamp":1733933898,"startTime":"0","endTime":"0","summary":"        *      个股走势的 Eikon 搜索字符串：[STXBZ］        *      The Day Ahead 新闻通讯：          *      The Morning News Call时事通讯：      12月11日 - 华尔街主要股指周三上涨，此前的通胀数据维持了对美联储本月晚些时候降息的押注不变。美东时间10:30，道琼斯工业平均指数  上涨0.03%，报44,259.91点。标普500指数  上涨0.66%，报6,074.64点；纳斯达克综合指数  上涨1.26%，报19,935.91点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMZN","AVGO","DOG","FIGS","RCKT","AVGOP","UDOW","LUV","TQQQ","DNUT","AZO",".SPX","SFIX",".DJI","ANVS","EGP","GM","RDDT","LOAR","NQmain","ALK","GTLS","CCB","QTTB","RLAY","DJX","ACI","PLD",".IXIC","XOM","CLRB","CADL","GEV","M","MNKD","CGON","OMC","MNQmain","FLNC","LENZ","SIRI","PLAY","QID","SDOW","MDLZ","PDCO","PSQ","IBRX","QLD"],"gpt_icon":1},{"id":"2490639738","title":"Immunitybio, Inc.盘中异动 早盘大幅下跌29.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490639738","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490639738?lang=zh_cn&edition=full","pubTime":"2024-12-11 22:31","pubTimestamp":1733927512,"startTime":"0","endTime":"0","summary":"北京时间2024年12月11日22时31分，Immunitybio, Inc.股票出现波动，股价大幅跳水29.59%。Immunitybio, Inc.股票所在的生物技术行业中，整体涨幅为0.20%。Immunitybio, Inc.公司简介：ImmunityBio Inc 是一家临床阶段的综合性生物技术公司，致力于发现，开发和商业化下一代免疫和细胞疗法，以增强天然免疫系统，驱动和维持免疫反应。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211223152ab6fca10&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211223152ab6fca10&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CADL","BK4139","IBRX","BK4539"],"gpt_icon":0},{"id":"2490850527","title":"BUZZ--美国股票走势-埃克森美孚、Mondelez International、梅西百货","url":"https://stock-news.laohu8.com/highlight/detail?id=2490850527","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490850527?lang=zh_cn&edition=full","pubTime":"2024-12-11 22:11","pubTimestamp":1733926289,"startTime":"0","endTime":"0","summary":"由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241211:nL4T3NC12G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2249611893.SGD","LU2602419157.SGD","LU0612318385.USD","SG9999014567.USD","XOM","LU1929549753.HKD","LUV","FIGS","SG9999015341.SGD","LU2505996509.AUD","PLAY","BK4559","ALK","EGP","GEV","FLNC","SFIX","LU0011850046.USD","CGON","LU0130103400.USD","LU1481011911.USD","OMC","LU1150488218.USD","PDCO","MNKD","LU0070302665.USD","LU1430597077.USD","QTTB","LU1732799900.SGD","LU1066053197.SGD","IBRX","CLRB","LU0738911758.USD","LU0170899867.USD","PLD","LU0345770308.USD","M","CADL","RCKT","RJF","ANVS","RLAY","LU0320765489.SGD","DNUT","GM","BK4077","LU0795875086.SGD","SIRI","MDLZ"],"gpt_icon":1},{"id":"2490859965","title":"BUZZ-ImmunityBio 以 35% 的折扣定价发行 1 亿美元股票后暴跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2490859965","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490859965?lang=zh_cn&edition=full","pubTime":"2024-12-11 20:49","pubTimestamp":1733921375,"startTime":"0","endTime":"0","summary":" (更新)    12月11日 - ** 癌症疗法生产商ImmunityBio   股价盘前大跌19.6%至3.73美元*  * IBRX 以每股3美元的价格公开发售3330万股股票，募集资金总额约为1亿美元。** Jefferies 和 Piper Sandler 是此次发行的联合簿记管理人** 截至上次收盘，IBRX 股价年累计下跌 7.6","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IBRX"],"gpt_icon":0},{"id":"2490524855","title":"BUZZ--美国股票走势-通用汽车、GE Vernova、亚马逊","url":"https://stock-news.laohu8.com/highlight/detail?id=2490524855","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490524855?lang=zh_cn&edition=full","pubTime":"2024-12-11 20:10","pubTimestamp":1733919014,"startTime":"0","endTime":"0","summary":"由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"d039160368f49bf807e51f5d9290e21b","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241211:nL4T3NC0TW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2065171311.SGD","IBRX","FLNC","LU0724617625.USD","LU2111349929.HKD","LU0672654240.SGD","PLAY","LU1093756168.USD","BK4182","BK4139","BK4539","LU2125154778.USD","BK4551","LU0320765059.SGD","LUV","IE00B4YYXB79.USD","LU0642271901.SGD","IE00BJJMRX11.SGD","LU1988902786.USD","IE000YTNTUN2.SGD","SG9999015945.SGD","LU2361044949.HKD","GEV","IE00B1BXHZ80.USD","LU1064131342.USD","IE000KEQY171.SGD","LU2362540622.SGD","LU0772969993.USD","LU1509826696.USD","CGON","LU1084165304.USD","LU2242650005.HKD","LU0823421333.USD","LU0256863902.USD","LU0683600562.USD","AMZN","BK4535","LU1852331112.SGD","OMC","SFIX","RLAY","ALK","DNUT","IE00BFSS7M15.SGD","IE00B775H168.HKD","LU1633808545.USD","SG9999015986.USD","LU0417517546.SGD","GM","CLRB"],"gpt_icon":1},{"id":"2490321308","title":"BUZZ-ImmunityBio 因股票发行计划而下滑","url":"https://stock-news.laohu8.com/highlight/detail?id=2490321308","media":"路透中文","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490321308?lang=zh_cn&edition=full","pubTime":"2024-12-11 18:50","pubTimestamp":1733914258,"startTime":"0","endTime":"0","summary":"12月11日 -  ** 癌症疗法生产商ImmunityBioIBRX.O股价盘前下跌18.3%，至3.79美元 ** IBRX周二晚些时候宣布， ，计划公开发售股票，但没有透露规模。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241211:nL4T3NC0PD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IBRX"],"gpt_icon":0},{"id":"2489231419","title":"Immunitybio, Inc.盘中异动 早盘股价大涨5.36%报4.82美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2489231419","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489231419?lang=zh_cn&edition=full","pubTime":"2024-12-06 23:06","pubTimestamp":1733497576,"startTime":"0","endTime":"0","summary":"北京时间2024年12月06日23时06分，Immunitybio, Inc.股票出现异动，股价快速拉升5.36%。截至发稿，该股报4.82美元/股，成交量48.9244万股，换手率0.07%，振幅4.81%。Immunitybio, Inc.股票所在的生物技术行业中，整体涨幅为0.68%。Immunitybio, Inc.公司简介：ImmunityBio Inc 是一家临床阶段的综合性生物技术公司，致力于发现，开发和商业化下一代免疫和细胞疗法，以增强天然免疫系统，驱动和维持免疫反应。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120623061798e5e374&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120623061798e5e374&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IBRX"],"gpt_icon":0},{"id":"2488692860","title":"Immunitybio, Inc.盘中异动 临近午盘股价大跌5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2488692860","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488692860?lang=zh_cn&edition=full","pubTime":"2024-12-04 00:36","pubTimestamp":1733243796,"startTime":"0","endTime":"0","summary":"北京时间2024年12月04日00时36分，Immunitybio, Inc.股票出现异动，股价急速跳水5.03%。截至发稿，该股报4.72美元/股，成交量121.072万股，换手率0.17%，振幅5.13%。Immunitybio, Inc.股票所在的生物技术行业中，整体跌幅为0.29%。Immunitybio, Inc.公司简介：ImmunityBio Inc 是一家临床阶段的综合性生物技术公司，致力于发现，开发和商业化下一代免疫和细胞疗法，以增强天然免疫系统，驱动和维持免疫反应。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204003636abf334d3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204003636abf334d3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IBRX"],"gpt_icon":0},{"id":"2486903884","title":"Immunitybio, Inc.盘中异动 股价大涨5.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486903884","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486903884?lang=zh_cn&edition=full","pubTime":"2024-11-25 22:39","pubTimestamp":1732545545,"startTime":"0","endTime":"0","summary":"北京时间2024年11月25日22时39分，Immunitybio, Inc.股票出现波动，股价大幅上涨5.29%。Immunitybio, Inc.股票所在的生物技术行业中，整体涨幅为1.29%。Immunitybio, Inc.公司简介：ImmunityBio Inc 是一家临床阶段的综合性生物技术公司，致力于发现，开发和商业化下一代免疫和细胞疗法，以增强天然免疫系统，驱动和维持免疫反应。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125223905abddfe43&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125223905abddfe43&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IBRX"],"gpt_icon":0},{"id":"2485443658","title":"Immunitybio, Inc.盘中异动 急速上涨5.01%报5.12美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485443658","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485443658?lang=zh_cn&edition=full","pubTime":"2024-11-22 02:00","pubTimestamp":1732212032,"startTime":"0","endTime":"0","summary":"北京时间2024年11月22日02时00分，Immunitybio, Inc.股票出现异动，股价大幅拉升5.01%。截至发稿，该股报5.12美元/股，成交量192.393万股，换手率0.28%，振幅5.68%。Immunitybio, Inc.股票所在的生物技术行业中，整体涨幅为0.71%。Immunitybio, Inc.公司简介：ImmunityBio Inc 是一家临床阶段的综合性生物技术公司，致力于发现，开发和商业化下一代免疫和细胞疗法，以增强天然免疫系统，驱动和维持免疫反应。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122020032abd53df9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122020032abd53df9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IBRX"],"gpt_icon":0},{"id":"2484143048","title":"Immunitybio, Inc.盘中异动 早盘快速下挫5.05%报5.08美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484143048","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484143048?lang=zh_cn&edition=full","pubTime":"2024-11-20 23:07","pubTimestamp":1732115244,"startTime":"0","endTime":"0","summary":"北京时间2024年11月20日23时07分，Immunitybio, Inc.股票出现异动，股价快速下挫5.05%。截至发稿，该股报5.08美元/股，成交量63.7562万股，换手率0.09%，振幅4.86%。Immunitybio, Inc.股票所在的生物技术行业中，整体涨幅为0.49%。Immunitybio, Inc.公司简介：ImmunityBio Inc 是一家临床阶段的综合性生物技术公司，致力于发现，开发和商业化下一代免疫和细胞疗法，以增强天然免疫系统，驱动和维持免疫反应。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120230724971a7b5b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120230724971a7b5b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IBRX"],"gpt_icon":0},{"id":"1172442031","title":"异动解读 | Immunitybio, Inc.盘中大涨5.19%,业绩向好或是主因","url":"https://stock-news.laohu8.com/highlight/detail?id=1172442031","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1172442031?lang=zh_cn&edition=full","pubTime":"2024-11-19 23:04","pubTimestamp":1732028665,"startTime":"0","endTime":"0","summary":"Immunitybio, Inc.今日盘中股价大涨5.19%,引发市场广泛关注。根据相关新闻报道显示,公司2024财年第三财季净利润虽然为负值,但同比增长10.31%,营业收入6.11百万美元更是同比大增7351.22%,这或是导致该股大涨的主要原因之一。另外,公司最新财报数据显示,其资产负债比为0.33,流动比率为0.03,短期偿债能力有待加强。作为一家生物技术公司,Immunitybio主攻免疫和细胞疗法,目前主要产品包括膀胱癌、肺癌等重大疾病领域,市场空间广阔。上述正面因素的影响下,该股盘中出现大涨表现。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | Immunitybio, Inc.盘中大涨5.19%,业绩向好或是主因","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["IBRX"],"gpt_icon":0},{"id":"2484928284","title":"Immunitybio, Inc.盘中异动 早盘大幅上涨5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484928284","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484928284?lang=zh_cn&edition=full","pubTime":"2024-11-19 22:39","pubTimestamp":1732027198,"startTime":"0","endTime":"0","summary":"北京时间2024年11月19日22时39分，Immunitybio, Inc.股票出现波动，股价快速上涨5.09%。Immunitybio, Inc.股票所在的生物技术行业中，整体跌幅为0.53%。Immunitybio, Inc.公司简介：ImmunityBio Inc 是一家临床阶段的综合性生物技术公司，致力于发现，开发和商业化下一代免疫和细胞疗法，以增强天然免疫系统，驱动和维持免疫反应。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111922395998e43826&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111922395998e43826&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IBRX","BK4139"],"gpt_icon":0},{"id":"2484915368","title":"Immunitybio, Inc.2024财年第三财季实现净利润-85.73百万美元，同比增加10.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484915368","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484915368?lang=zh_cn&edition=full","pubTime":"2024-11-19 18:00","pubTimestamp":1732010415,"startTime":"0","endTime":"0","summary":"11月19日，Immunitybio, Inc.公布财报，公告显示公司2024财年第三财季净利润为-85.73百万美元，同比增加10.31%；其中营业收入为6.11百万美元，同比增加7351.22%，每股基本收益为-0.12美元。从资产负债表来看，Immunitybio, Inc.总负债11.09亿美元，其中短期债务9.20百万美元，资产负债比为0.33，流动比率为0.03。机构评级：截至2024年11月19日，当前有3家机构对Immunitybio, Inc.目标价做出预测，其中目标均价为14.25美元，其中最低目标价为4.75美元，最高目标价为30.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119180022a24561a5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119180022a24561a5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IBRX"],"gpt_icon":0},{"id":"2484672170","title":"Immunitybio, Inc.盘中异动 大幅上涨5.01%报4.72美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484672170","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484672170?lang=zh_cn&edition=full","pubTime":"2024-11-18 23:35","pubTimestamp":1731944101,"startTime":"0","endTime":"0","summary":"北京时间2024年11月18日23时35分，Immunitybio, Inc.股票出现波动，股价快速上涨5.01%。Immunitybio, Inc.股票所在的生物技术行业中，整体涨幅为0.01%。Immunitybio, Inc.公司简介：ImmunityBio Inc 是一家临床阶段的综合性生物技术公司，致力于发现，开发和商业化下一代免疫和细胞疗法，以增强天然免疫系统，驱动和维持免疫反应。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118233502971a7383&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118233502971a7383&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IBRX","BK4139"],"gpt_icon":0},{"id":"2483533118","title":"Immunitybio, Inc.盘中异动 股价大涨5.07%报5.08美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483533118","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483533118?lang=zh_cn&edition=full","pubTime":"2024-11-15 04:19","pubTimestamp":1731615577,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日04时19分，Immunitybio, Inc.股票出现波动，股价急速上涨5.07%。截至发稿，该股报5.08美元/股，成交量387.078万股，换手率0.56%，振幅8.70%。Immunitybio, Inc.股票所在的生物技术行业中，整体跌幅为1.38%。Immunitybio, Inc.公司简介：ImmunityBio Inc 是一家临床阶段的综合性生物技术公司，致力于发现，开发和商业化下一代免疫和细胞疗法，以增强天然免疫系统，驱动和维持免疫反应。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115041937971a6a1e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115041937971a6a1e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IBRX"],"gpt_icon":0},{"id":"2482008447","title":"免疫生物公司报告本季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2482008447","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482008447?lang=zh_cn&edition=full","pubTime":"2024-11-12 23:29","pubTimestamp":1731425393,"startTime":"0","endTime":"0","summary":"免疫生物公司报告本季度业绩 - 收益摘要Immunitybio Inc IBRX.OQ报告本季度调整后每股亏损12美分，高于去年同期的每股-19美分。三位分析师对该季度的平均预期是每股亏损 18 美分。华尔街预期为每股-19 美分至-17 美分。该公司一季度亏损8573万美元。Immunitybio Inc股价本季度上涨了46.5%，今年迄今为止上涨了8.6%。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241112:nL4S3MJ1Q0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IBRX"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.immunitybio.com","stockEarnings":[{"period":"1week","weight":-0.0871},{"period":"1month","weight":-0.4626},{"period":"3month","weight":-0.2557},{"period":"6month","weight":-0.6391},{"period":"1year","weight":-0.3578},{"period":"ytd","weight":-0.4781}],"compareEarnings":[{"period":"1week","weight":-0.0221},{"period":"1month","weight":0.0006},{"period":"3month","weight":0.0397},{"period":"6month","weight":0.0851},{"period":"1year","weight":0.2499},{"period":"ytd","weight":0.243}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"ImmunityBio, Inc.于2002年10月7日在伊利诺伊州ZelleRx Corporation公司的名义下注册成立，于2010年1月22日，公司更名为Conkwest股份有限公司。ImmunityBio是一家领先的后期免疫疗法公司，可激活先天性（NK细胞和巨噬细胞）和适应性（T细胞）免疫系统，以治疗肿瘤学和传染病中严重的未满足需求。他们是现成的自然杀伤（NK）细胞疗法，自体/同种异体记忆NK细胞（m-ceNK）的临床剂型的领先生产商，以及抗体细胞因子融合蛋白，白蛋白结合化学疗法的全面平台免疫调节剂和疫苗载体。通过组合这些NK，巨噬细胞和T细胞活化平台，他们相信ImmunityBio引领免疫疗法领域，跨多种肿瘤类型和感染性疾病进行后期临床开发。","yearOnYearQuotes":[{"month":1,"riseRate":0.222222,"avgChangeRate":-0.010395},{"month":2,"riseRate":0.555556,"avgChangeRate":0.03495},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.083743},{"month":4,"riseRate":0.555556,"avgChangeRate":0.042504},{"month":5,"riseRate":0.333333,"avgChangeRate":0.053418},{"month":6,"riseRate":0.333333,"avgChangeRate":0.147898},{"month":7,"riseRate":0.444444,"avgChangeRate":-0.024912},{"month":8,"riseRate":0.3,"avgChangeRate":-0.116269},{"month":9,"riseRate":0.3,"avgChangeRate":-0.041956},{"month":10,"riseRate":0.5,"avgChangeRate":0.035321},{"month":11,"riseRate":0.7,"avgChangeRate":0.13572},{"month":12,"riseRate":0.4,"avgChangeRate":0.071138}],"exchange":"NASDAQ","name":"ImmunityBio, Inc.","nameEN":"ImmunityBio, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"ImmunityBio, Inc.(IBRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供ImmunityBio, Inc.(IBRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"ImmunityBio, Inc.,IBRX,ImmunityBio, Inc.股票,ImmunityBio, Inc.股票老虎,ImmunityBio, Inc.股票老虎国际,ImmunityBio, Inc.行情,ImmunityBio, Inc.股票行情,ImmunityBio, Inc.股价,ImmunityBio, Inc.股市,ImmunityBio, Inc.股票价格,ImmunityBio, Inc.股票交易,ImmunityBio, Inc.股票购买,ImmunityBio, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"ImmunityBio, Inc.(IBRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供ImmunityBio, Inc.(IBRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}